+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report by Product (Vials, Bottles, Cartridges & Syringes, Ampoules), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2019 - 2025

  • ID: 4582064
  • Report
  • 150 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Ardagh Group S.A
  • Beatson Clark
  • Bormioli Pharma S.r.l
  • Corning Incorporated
  • Gerresheimer AG
  • Nipro Corporation
  • MORE
The global pharmaceutical glass packaging market size is projected to reach USD 22.05 billion by 2025, according to this report. It is expected to expand at a CAGR of 6.4% during the forecast period. Governments in developing regions are expanding their public or private healthcare coverage which is expected to drive the demand for this packaging.

Pharmaceutical glass packaging plays a major role in increasing shelf life of the drugs. Growing requirement for brand enhancement and differentiation in an increasingly competitive environment, R&D activities, awareness regarding environmental issues, and adoption of new regulatory requirements for recycling of packaging products are some of the key market drivers.

The market size as well as penetration of glass vials is anticipated to remain high over the forecast period owing to the high inertness of these products to majority of chemicals. Moreover, the vials prevent atmospheric gases such as oxygen as well as carbon dioxide from entering the container, which is anticipated to surge the product demand in the forthcoming years.

The pharmaceutical glass packaging market is expected to face a stiff composition from other plastic substitutes such as Polyethylene Terephthalate (PET), High-density Polyethylene (HDPE), Low-density Polyethylene (LDPE), and Polystyrene (PS) not only for the development of non-parenteral containers but parenteral containers as well, which is expected to hinder the market growth in near future.

Asia Pacific is estimated to witness the fastest CAGR of over 9% during the forecast period on account of increasing production volumes in emerging economies including India and China. China is expected to emerge as one of the major consumers of pharmaceutical glass packaging.

Further key findings from the report suggest:
  • In terms of revenue, pharmaceutical glass bottles is projected to ascend at a CAGR of 4.8% over the forecast period
  • Cartridges and syringes contributed approximately over 9.8% to the total market in 2018
  • Pharmaceutical glass packaging for generic drug types led the global market, constituting a revenue share of over 71.3% in 2018
  • In terms of product, vials emerged as the second largest segment in 2018, registering a revenue of USD 4.66 billion. The segment is expected to expand at a CAGR of 7.0% in the forthcoming years
  • Biologics accounted for 6 of the top 8 drugs, in terms of revenue, in 2018. Biologics are attractive for the global pharma industry as they provide benefits in the undeserved therapeutic areas, which is anticipated to fuel the growth
  • North America pharmaceutical glass packaging market is anticipated to expand at a CAGR of 3.6% in the forthcoming years. Expiration of patents, rise in aging population, and various efforts from governments and health care service providers to increase consumer awareness are likely to propel the utilization of generic drugs in the region
  • SCHOTT AG, Gerresheimer AG, Nipro Pharmapackaging, Corning Incorporated, Şişecam Group, Stevanato Group, Arab Pharmaceutical Glass Co., Beatson Clark, and Owens-Illinois, Inc. are some of the key manufacturers of pharmaceutical glass products such as ampoules, cartridges and syringes, vials, and bottles

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ardagh Group S.A
  • Beatson Clark
  • Bormioli Pharma S.r.l
  • Corning Incorporated
  • Gerresheimer AG
  • Nipro Corporation
  • MORE
Chapter 1 Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased Database
1.1.2 Internal database
1.1.3 Secondary Sources
1.1.4 Third Party Perspective
1.1.5 Primary Research
1.2 Information Analysis & Data Analysis Models
1.3 List to Data Sources

Chapter 2 Executive Summary
2.1 Market Insights
2.2 Segmental Insights
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Value Chain Analysis
3.3.1 Raw Material Trends
3.3.1.1 Major Raw Material Analysis
3.3.1.2 Procurement Best Practices
3.3.2 Manufacturing trends
3.3.2.1 Technology Trends
3.3.2.2 Outsourcing and contract manufacturing trends
3.3.3 Cost structure and profit margin analysis
3.3.3.1 Profit margin and cost analysis
3.3.4 Sales channel analysis
3.3.5 Vendor selection criteria
3.4 Regulatory Framework
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Growth of pharmaceutical industry in emerging economies
3.5.1.2 Commodity value of glass increased with recyclability:
3.5.2 Market restraint Analysis
3.5.2.1 Increased relevance of alternate sources
3.5.2.2 Challenges associated with glass surface
3.5.3 Industry challenges
3.6 Business Environment Analysis
3.6.1 Porter’s Analysis
3.6.1.1 Threat of new entrants
3.6.1.2 Bargaining power of suppliers
3.6.1.3 Bargaining power of buyers
3.6.1.4 Threat of substitutes
3.6.1.5 Competitive rivalry
3.6.2 PESTLE Analysis
3.6.2.1 Political Landscape
3.6.2.2 Environmental Landscape
3.6.2.3 Social Landscape
3.6.2.4 Technology Landscape
3.6.2.5 Economic Landscape
3.6.2.6 Legal Landscape
3.6.3 Major Deals & Strategic Alliances Analysis
3.6.3.1 Mergers & Acquisitions
3.6.3.2 Licensing & partnership
3.7 Market Entry Strategy

Chapter 4 Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Pharmaceutical Glass Packaging Market: Product Movement Analysis, 2018 & 2025
4.3. Vials
4.3.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
4.4 Bottles
4.4.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
4.5 Cartridges & Syringes
4.5.1Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
4.6 Ampoules
4.6.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)

Chapter 5 Pharmaceutical Glass Packaging Market: Drug Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Pharmaceutical Glass Packaging Market: Drug Type Movement Analysis, 2018 & 2025
5.3 Generic
5.3.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
5.4 Branded
5.4.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
5.5 Biologic
5.5.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)

Chapter 6 Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis
6.1 Definition & Scope
6.2 Pharmaceutical Glass Packaging Market: Regional movement analysis, 2018 & 2025
6.3 North America
6.3.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.3.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.3.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.3.4 Market estimates and forecast, by distribution channel, 2014 - 2025 (Million Units) (USD Million)
6.3.5 U.S.
6.3.5.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.3.5.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.3.5.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.4 Europe
6.4.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.4.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.4.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.4.4 U.K.
6.4.4.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.4.4.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.4.4.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.4.5 Germany
6.4.5.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.4.5.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.4.5.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.4.6 France
6.4.6.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.4.6.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.4.6.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.4.7 Italy
6.4.7.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.4.7.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.4.7.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.4.8 Spain
6.4.8.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.4.8.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.4.8.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.5 Asia Pacific
6.5.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.5.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.5.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.5.4 China
6.5.4.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.5.4.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.5.4.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.5.5 Japan
6.5.5.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.5.5.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.5.5.4 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.5.6 India
6.5.6.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.5.6.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.5.6.4 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.5.7 India
6.5.7.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.5.7.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.5.7.4 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.6 Central & South America
6.6.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.6.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.6.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.6.4 Brazil
6.6.4.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.6.4.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.6.4.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)
6.7 Middle East & Africa (MEA)
6.7.1 Market estimates and forecast, 2014 - 2025 (Million Units) (USD Million)
6.7.2 Market estimates and forecast, by Product, 2014 - 2025 (Million Units) (USD Million)
6.7.3 Market estimates and forecast, by drug type, 2014 - 2025 (Million Units) (USD Million)

Chapter 7 Competitive Analysis
7.1 Key Players’ Recent Developments & Their Impact
7.2 Key Innovators, Market Leader, and Emerging Players
7.3 Vendor Landscape
7.3.1 List of key distributors & channel partners
7.3.2 Key customers
7.4 Public Companies
7.4.1 Company market position analysis
7.4.2 Company ranking
7.4.3 Competitive dashboard analysis
7.4.4 Market differentiators
7.4.5 Synergy Analysis: Major Deals & Strategic Alliances
7.4.6 SWOT Analysis of Public companies
7.5 Private Companies
7.5.1 List of key emerging companies/technology disruptors/innovators
7.5.2 Geographical Presence
7.5.3 Company market position analysis

Chapter 8 Company Profiles
8.1 Corning Incorporated
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Form Benchmarking
8.1.4 Strategic Initiatives
8.2 Nipro Corporation
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Form Benchmarking
8.2.4 Strategic Initiatives
8.3 SGD S.A
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Form Benchmarking
8.4 Stölzle-Oberglas GmbH
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Form Benchmarking
8.5 Bormioli Pharma S.r.l
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Form Benchmarking
8.6 West Pharmaceutical Services, Inc.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Form Benchmarking
8.6.4 Strategic Initiatives
8.7 Schott AG
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Form Benchmarking
8.7.4 Strategic Initiatives
8.8 Gerresheimer AG
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Form Benchmarking
8.8.4 Strategic Initiatives
8.9 Shandong Medicinal Glass Co., Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Form Benchmarking
8.10 Beatson Clark
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Form Benchmarking
8.11 Ardagh Group S.A
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Form Benchmarking
8.11.4 Strategic Initiatives
8.12 Arab Pharmaceutical Glass Co.
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Form Benchmarking
8.12.4 Strategic Initiatives
8.13 Piramal Enterprises Ltd.
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Form Benchmarking
8.14 Şişecam Group
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Form Benchmarking
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Corning Incorporated
  • Nipro Corporation
  • SGD S.A
  • Stölzle-Oberglas GmbH
  • Bormioli Pharma S.r.l
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • Shandong Medicinal Glass Co., Ltd.
  • Beatson Clark
  • Ardagh Group S.A
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Şişecam Group
Note: Product cover images may vary from those shown
Adroll
adroll